39406 protein, a novel seven transmembrane protein

An isolated mucleic acid molecule selected from the group consisting of:

• a) a nucleic acid molecule comprising a mucleotide sequence which is at least 70% identical to the nucleotide sequence of SEQ ID NO:1 or the nucleotide sequence of the cDNA insert of the plasmid deposited with ATCC as Patent Deposit No. PTA-1848, wherein said nucleotide sequence encodes a polypeptide having biological activity;
• b) a nucleic acid molecule comprising a fragment of at least 20 nucleotides of the cDNA insert of the plasmid deposited with ATCC as Patent Deposit No. PTA-1848;
• c) a nucleic acid molecule which encodes a polypeptide comprising the amino acid sequence of SEQ ID NO:2, or the amino acid sequence endoded by the cDNA insert of the plasmid deposited with the ATCC as Patent Deposit No. PTA-1848;
• d) a nucleic acid molecule which encodes a fragment of a polypeptide comprising the amino acid sequence of SEQ ID NO2, or the amino acid sequence encoded by the cDNA insert of the plasmid deposited with the ATCC as Patent Deposit No. PTA-1848, wherein the fragment comprises at least 15 contiguous amino acids of SEQ ID NO:2, or the amino acid sequence encoded by the cDNA insert of the plasmid deposited with the ATCC as Patent Deposit No. PTA-1848;
• e) a nucleic acid molecule which encodes a naturally occurring allelic variant of a biologically active polypeptide comprising the amino acid sequence of SEQ ID NO2:, or the amino acid sequence encoded by the cDNA insert of the plasmid deposited with the ATCC as Patent Deposit No. PTA-1848, wherein the nucleic acid molecule hybridizes to a nucleic acid molecule comprising the complement of SEQ ID NO:1 or SEQ ID NO:3 under stringent conditions;
• and
• f) a nucleic acid molecule comprising the complement of a), b), c), d), or e).